Recent News

• 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference 2025
• 06.06.2025 - Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
• 06.06.2025 - Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
• 05.15.2025 - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Recent Filings

• 06.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.06.2025 - EX-99.1 EX-99.1
• 06.06.2025 - 8-K Current report
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors